Related Experiment Video
Updated: Jun 23, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Cutaneous tuberculosis: Prevention, management, challenges and future perspectives
Geeti Khullar1, Parul Verma2, Satyaki Ganguly3
1Department of Dermatology, Vardhman Mahavir Medical College (VMMC) and Safdarjung, Hospital, New Delhi, India.
None:
Treatment of cutaneous tuberculosis (CTB) can be challenging due to multiple factors. We discuss the role of Bacillus Calmette Guérin vaccination in the prevention of CTB, complications associated with CTB, drug regimens used for treatment in adults and children, various challenges in the management, including drug resistance, existing lacunae, and future directions in the diagnosis and treatment of CTB.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Smallpox
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...